These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5075092)

  • 21. Antiarrhythmic effects of aspirin during nonthrombotic coronary occlusion.
    Moschos CB; Haider B; De La Cruz C; Lyons MM; Regan TJ
    Circulation; 1978 Apr; 57(4):681-4. PubMed ID: 630676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of aspirin for coronary artery disease.
    Fuster V; Cohen M; Chesebro JH
    Am J Cardiol; 1988 Mar; 61(8):637-40. PubMed ID: 3278582
    [No Abstract]   [Full Text] [Related]  

  • 23. Platelets, thrombosis and coronary artery disease.
    Genton E; Weily HS; Steele PP
    Adv Cardiol; 1973; 9():29-39. PubMed ID: 4582913
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prostaglandins, blood platelets, and thrombosis].
    Bousser MG
    Ann Med Interne (Paris); 1973 Apr; 124(4):351-4. PubMed ID: 4352683
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet suppressive therapy.
    Turpie AG; Hirsh J
    Br Med Bull; 1978 May; 34(2):183-90. PubMed ID: 350343
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet drugs in the management of patients with thrombotic disorders.
    Harker LA
    Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905
    [No Abstract]   [Full Text] [Related]  

  • 29. Aspirin and dipyridamole and their limitations in the therapy of coronary artery disease.
    Rowe GG; Folts JD
    Clin Cardiol; 1990 Mar; 13(3):165-70. PubMed ID: 2182246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 31. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA; Hirsh J; Gent M; Genton E
    Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
    [No Abstract]   [Full Text] [Related]  

  • 32. [Aspirin resistance: position paper of the working group on aspirin resistance of the international society on thrombosis and haemostasis].
    Boskholov BP
    Kardiologiia; 2005; 45(7):75-6. PubMed ID: 16091668
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
    Weiss HJ
    Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.
    Mazur P; Frołow M; Niżankowski R; Sadowski J; Undas A
    Platelets; 2013; 24(2):151-5. PubMed ID: 22497730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of the beta-blocking agent atenolol on arrhythmias especially ventricular fibrillation and fibrillation threshold after acute experimental coronary artery occlusion (author's transl)].
    Abendroth RR; Meesmann W; Stephan K; Schley G; Hübner H
    Z Kardiol; 1977 Jul; 66(7):341-50. PubMed ID: 899134
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative effects of verapamil and nifedipine on reactive hyperemia and ventricular arrhythmias during coronary artery reperfusion.
    Ribeiro LG; DeBauche TL; Brandon TA; Maroko PR; Miller RR
    Eur Heart J; 1980 Dec; 1(Suppl B):31-5. PubMed ID: 7348214
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin.
    Josa M; Lie JT; Bianco RL; Kaye MP
    Am J Cardiol; 1981 Jun; 47(6):1248-54. PubMed ID: 6972158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of a thromboxane receptor antagonist and aspirin in experimental arterial thrombosis.
    Schumacher WA; Heran CL; Youssef S; Megill JR; Michel I; Durham SK
    Haemostasis; 1993; 23(4):219-28. PubMed ID: 8314172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of antiarrhythmic agents during acute myocardial ischemia and the role of heart rate.
    Hope RR; Williams DO; el-Sherif N; Lazzara R; Scherlag BJ
    Circulation; 1974 Sep; 50(3):507-14. PubMed ID: 4416250
    [No Abstract]   [Full Text] [Related]  

  • 40. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.